OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome - Concepedia

Concepedia

Publication | Open Access

OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome

DOI Full Paper Access

21

Citations

0

References

2018

Year

Thomas Dörner, Margit Zeher, Ute Laessing, Frédérique Chaperon, Stefan Buck, Anke Hasselberg, M-A Valentin, Shuren Ma, Maciej Cabanski, Christoph Kalis,

Annals of the Rheumatic Diseases

No additional data available for this publication yet. Check back later!